Tomasz Skorski, MD, PhD, DSc, Director of the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, is the senior author on a recent study published in the journal Cancer Research which identified specific leukemia gene mutations and the mechanisms by which they regulate DNA repair and respond to PARP inhibitors. The research was led by scientists from the Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center. News-Medical.net highlighted the news.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University
Posted November 22, 2024A novel “on-the-table” therapeutic strategy with a total procedure time of less than one hour can safely reduce the size of blood clots lodged in the pulmonary arteries and eliminate the need for post-procedural drug infusion in an intensive care unit, according to Katz School of Medicine research.
Read MoreHealio Highlights Dr. Kristin Criner’s Session at the GOLD International COPD Conference
Posted November 21, 2024Healio highlighted the key takeaways from Dr. Criner’s session on how to identify and treat patients with COPD plus diabetes or osteoporosis.
Read More